Breaking News

You are here » Indian-Commodity  :  Commodities  :  Crude Oil  :  Crude palm oil futures trade lower on MCX

14-May2018

Crude palm oil futures trade lower on MCX

Crude palm oil futures traded lower on MCX, as traders locked-in gains at prevailing higher levels after the prices rose on expectation of higher imports of palm oil. Besides, muted demand in the physical market also led to the decline in CPO price at future trade.

The contract for May delivery was trading at Rs 658.50, down by 0.39% or Rs 2.60 from its previous closing of Rs 661.10. The open interest of the contract stood at 4166 lots.

The contract for June delivery was trading at Rs 659.40, down by 0.27% or Rs 1.80 from its previous closing of Rs 661.20. The open interest of the contract stood at 2556 lots on MCX.


Related News

View all news

Crude oil futures settle higher on Thursday

Extending gains for second straight session, crude oil futures settled higher on Thursday, despite official data from the Energy Information Administration (EIA) showing a bigger than expected increase......

Crude oil futures snap 12-day losing streak on Wednesday

Snapping 12-day losing streak, crude oil futures ended higher on Wednesday amid strengthening signals that the Organization of the Petroleum Exporting Countries (OPEC) and allied producers are considering......

Crude oil futures end significantly lower on global demand concerns

Extending southward journey for 12th straight session, crude oil futures ended significantly lower on Tuesday, as rising output and likely fall in demand for oil due to weak outlook for global economic......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......